Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 3/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.68 |
| ▸ | MEN1 | O00255 | 3/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.68 |
| ▸ | PPARG | P37231 | 1/20 | 0.67 |
| ▸ | PPARD | Q03181 | 1/20 | 0.67 |
| ▸ | MAPT | P10636 | 4/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.60 |
| ▸ | LMNA | P02545 | 3/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.60 |
| ▸ | GAA | P10253 | 2/20 | 0.60 |
| ▸ | HTT | P42858 | 1/20 | 0.60 |
| ▸ | NPC1 | O15118 | 3/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | CNR2 | P34972 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 2/20 | 0.56 |
| ▸ | RAB9A | P51151 | 2/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20739714 | 1.00 | PPARA (0.68) | PPARAALDH1A1MEN1KMT2APPARG | |
| SCHEMBL11837062 | 1.00 | PPARA (0.68) | PPARAALDH1A1MEN1KMT2APPARG | |
| SCHEMBL20723736 | 1.00 | PPARA (0.68) | PPARAALDH1A1MEN1KMT2APPARG | |
| SCHEMBL20739716 | 1.00 | PPARA (0.68) | PPARAALDH1A1MEN1KMT2APPARG | |
| SCHEMBL20723798 | 1.00 | PPARA (0.68) | PPARAALDH1A1MEN1KMT2APPARG | |
| SCHEMBL20739715 | 1.00 | PPARA (0.68) | PPARAALDH1A1MEN1KMT2APPARG | |
| SCHEMBL20723695 | 1.00 | PPARA (0.68) | PPARAALDH1A1MEN1KMT2APPARG | |
| SCHEMBL357725 | 0.99 | PPARA (0.70) | PPARAALDH1A1MEN1KMT2APPARG | |
| Hydrochloric Acid SCHEMBL29175090 | 0.97 | PPARA (0.68) | PPARAALDH1A1MEN1KMT2APPARG | |
| N-Butyleugenol SCHEMBL18035642 | 0.94 | ALDH1A1 (0.71) | PPARAALDH1A1MEN1KMT2APPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10702475-B2 | Liposome containing compositions and their use in personal care and food products | RIGG RICHARD (US) | 2020-07-07 | — | — | US | claimed |
| US-20190070114-A1 | Liposome Containing Compositions and Their Use in Personal Care and Food Products | RIGG RICHARD (US) | 2019-03-07 | — | — | US | claimed |
| WO-2019030643-A1 | COMPOSITIONS OF EUGENOL DERIVATIVES FOR TREATMENT OF VISCERAL LEISHMANIASIS | FOUNDATION FOR NEGLECTED DISEASE RESEARCH (IN) | 2019-02-14 | — | — | WO | claimed |
| CN-103347386-B | Antimicrobial compositions | 荷兰联合利华有限公司 | 2016-08-10 | — | — | CN | claimed |
| EP-2672828-B1 | ANTIMICROBIAL COMPOSITION | UNILEVER NV (NL) | 2015-04-29 | — | — | EP | claimed |
| CN-102906237-B | hard surface treatment composition | UNILEVER NEDERLAND B.V. (NL) | 2014-10-29 | — | — | CN | claimed |
| US-20140135297-A1 | AQUEOUS VOLATILE ORGANIC COMPOUND FREE DISINFECTANT AND/OR CLEANING COMPOSITION AND METHOD OF PREPARATION | ISP INVESTMENTS INC. (US) | 2014-05-15 | — | — | US | claimed |
| EP-2576747-B1 | HARD SURFACE TREATMENT COMPOSITION | UNILEVER NV (NL) | 2014-04-23 | — | — | EP | claimed |
| EP-2672828-A1 | ANTIMICROBIAL COMPOSITION | Unilever NV (NL) | 2013-12-18 | — | — | EP | claimed |
| US-20130316027-A1 | ANTIMICROBIAL COMPOSITION | CONOPCO, INC., D/B/A UNILEVER | 2013-11-28 | — | — | US | claimed |
| EP-2575753-A1 | SKIN TREATMENT COMPOSITION | Unilever NV (NL) | 2013-04-10 | — | — | EP | claimed |
| EP-2575744-A2 | SKIN TREATMENT COMPOSITION | Unilever NV (NL) | 2013-04-10 | — | — | EP | claimed |
| EP-2576747-A1 | HARD SURFACE TREATMENT COMPOSITION | Unilever NV (NL) | 2013-04-10 | — | — | EP | claimed |
| CN-102933191-A | Skin treatment composition | UNILEVER NV | 2013-02-13 | — | — | CN | claimed |
| CN-102905683-A | Skin treatment composition | UNILEVER NV | 2013-01-30 | — | — | CN | claimed |
| CN-102906237-A | Hard surface treatment composition | UNILEVER NV | 2013-01-30 | — | — | CN | claimed |
| WO-2012170841-A1 | AN AQUEOUS VOLATILE ORGANIC COMPOUND FREE DISINFECTANT AND/OR CLEANING COMPOSITION AND METHOD OF PREPARATION | ISP INVESTMENTS INC. (US) | 2012-12-13 | — | — | WO | claimed |
| WO-2012107390-A1 | ANTIMICROBIAL COMPOSITION | UNILEVER NV (NL) | 2012-08-16 | — | — | WO | claimed |
| EP-0950399-A2 | Fragrance compositions having antimicrobial activity | Takasago Institute For Interdisciplinary Science Inc. (US) | 1999-10-20 | — | — | EP | claimed |
| US-5965518-A | COMPRISING BETWEEN 3 AND 20% OF A PHENOLIC COMPOUND AND BETWEEN 20 AND 80% OF A NON-AROMATIC TERPINOID | TAKASAGO INSTITUTE FOR INTERDISCIPLINARY SCIENCE, INC. | 1999-10-12 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130316027-A1 | ANTIMICROBIAL COMPOSITION | ZC3HAV1, ZC3HAV1L, PICALM | PPARA 945/4885ALDH1A1 2925/4885MEN1 4199/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.